France· FR:68393033
TRH FERRING 200 microgrammes/1 ml, solution injectable
A protirelin product containing protiréline, registered in France by FERRING (FRANCE). The same ATC class is registered in 6 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Protirelin is registered in 6 of 19 countries.
Countries holding a registration under ATC V04CJ02 (protirelin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 3 of them publish a price we can compare per daily dose
Protirelin · ATC V04CJ02
6 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Japan
- Norwayprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PROTIRÉLINE
- Manufacturer
- FERRING (FRANCE)
- Country
- France (FR)
- ATC code
- V04CJ02
- ATC class
- Protirelin
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009301170401 ampoule unidose en verre de 1 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Protirelin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomProtirelin 200micrograms/1ml solution for injection ampoulesSpecial Order
- GermanyTrhFerring Gmbh
- NorwayTRH ferringFerring GmbH (2)
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Trh
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a00f2241-951a-4de5-a25f-4d758d0d8ed8 GET /v1/drugs/a00f2241-951a-4de5-a25f-4d758d0d8ed8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68393033",
"date_amm": "2017-10-20",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PROTIRÉLINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about protirelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.